https://www.clinicalobserver.com/ hourly 1 https://www.clinicalobserver.com/research hourly 0.8 https://www.clinicalobserver.com/policy hourly 0.8 https://www.clinicalobserver.com/biotech hourly 0.8 https://www.clinicalobserver.com/hospitals hourly 0.8 https://www.clinicalobserver.com/public-health hourly 0.8 https://www.clinicalobserver.com/opinion hourly 0.8 https://www.clinicalobserver.com/research/sacituzumab-tirumotecan-plus-pembrolizumab-improves-pfs-in-pd-l1-negative-nsclc 2026-10-25T18:29:17.849Z 0.6 https://www.clinicalobserver.com/public-health/nigeria-reports-first-bundibugyo-ebola-case-as-global-outbreak-tops-9-700 2026-10-25T18:13:00.430Z 0.6 https://www.clinicalobserver.com/biotech/tarlatamab-plus-durvalumab-cut-death-risk-58-in-first-line-small-cell-lung 2026-10-25T17:54:12.649Z 0.6 https://www.clinicalobserver.com/public-health/uganda-imposes-21-day-quarantine-on-citizens-returning-from-drc 2026-10-25T16:11:11.227Z 0.6 https://www.clinicalobserver.com/public-health/three-die-in-suspected-hantavirus-outbreak-on-atlantic-cruise-ship 2026-10-25T18:25:15.565Z 0.6 https://www.clinicalobserver.com/research/first-ebola-vaccine-trial-in-dr-congo-begins-in-bunia 2026-10-24T15:59:21.805Z 0.6 https://www.clinicalobserver.com/public-health/kenya-searches-for-missing-ugandan-ebola-contact-as-cases-rise-to-nine 2026-10-24T12:55:06.891Z 0.6 https://www.clinicalobserver.com/public-health/swiss-national-is-first-ebola-bundibugyo-case-in-nigeria 2026-10-25T17:10:13.893Z 0.6 https://www.clinicalobserver.com/public-health/kenya-reports-second-ebola-death-with-no-community-spread 2026-10-25T13:55:17.348Z 0.6 https://www.clinicalobserver.com/biotech/merck-and-moderna-report-phase-3-cancer-vaccine-data-early-after-leak 2026-10-25T09:09:55.179Z 0.6 https://www.clinicalobserver.com/public-health/nigeria-confirms-first-ebola-case-in-more-than-a-decade 2026-10-23T23:19:46.060Z 0.6 https://www.clinicalobserver.com/research/mrna-melanoma-vaccine-plus-keytruda-cut-recurrence-risk-by-42-in-phase-3 2026-10-24T05:54:35.690Z 0.6 https://www.clinicalobserver.com/biotech/brepocitinib-meets-primary-endpoint-in-two-phase-3-uveitis-trials 2026-10-23T21:29:30.681Z 0.6 https://www.clinicalobserver.com/biotech/izalontamab-brengitecan-cuts-progression-risk-by-59-in-hr-her2-breast-cancer 2026-10-23T20:59:24.574Z 0.6 https://www.clinicalobserver.com/hospitals/mass-general-brigham-cuts-staff-and-halves-home-hospital 2026-10-23T20:32:27.411Z 0.6 https://www.clinicalobserver.com/public-health/us-measles-cases-reach-4-588-as-pennsylvania-reports-1-338 2026-10-25T11:55:09.186Z 0.6 https://www.clinicalobserver.com/biotech/bristol-myers-squibb-reports-death-in-autoimmune-car-t-trial 2026-10-23T19:29:58.797Z 0.6 https://www.clinicalobserver.com/policy/fda-approves-bepirovirsen-for-chronic-hepatitis-b 2026-10-23T17:21:26.438Z 0.6 https://www.clinicalobserver.com/policy/fda-finalizes-software-labeling-guidance-for-drug-sponsors 2026-10-22T21:08:23.360Z 0.6 https://www.clinicalobserver.com/biotech/telehealth-platforms-prescribe-glp-1s-off-label-for-addiction 2026-10-22T20:47:08.158Z 0.6 https://www.clinicalobserver.com/research/pembrolizumab-plus-chemotherapy-improves-pcr-in-triple-negative-breast-cancer 2026-10-22T20:27:24.800Z 0.6 https://www.clinicalobserver.com/biotech/otsuka-reports-phase-3-data-showing-voyxact-cut-kidney-decline-risk-in-iga 2026-10-24T14:24:35.686Z 0.6 https://www.clinicalobserver.com/biotech/fda-accepts-biohaven-s-troriluzole-resubmission 2026-10-23T22:23:31.071Z 0.6 https://www.clinicalobserver.com/research/gilead-posts-phase-3-results-for-bictegravir-lenacapavir 2026-10-22T20:29:51.492Z 0.6 https://www.clinicalobserver.com/biotech/fda-approves-first-of-its-kind-chronic-hepatitis-b-treatment 2026-10-25T02:23:39.048Z 0.6 https://www.clinicalobserver.com/public-health/nigeria-confirms-travel-linked-ebola-case-as-africa-cdc-calls-crisis-meeting 2026-10-25T18:08:50.693Z 0.6 https://www.clinicalobserver.com/biotech/openai-acquires-orchestra-bio-deepening-ai-s-drug-development-push 2026-10-25T18:54:35.511Z 0.6 https://www.clinicalobserver.com/public-health/nigeria-confirms-first-ebola-case-as-regional-outbreak-spreads 2026-10-24T12:31:23.496Z 0.6 https://www.clinicalobserver.com/hospitals/nonprofit-hospital-mergers-expand-across-the-midwest 2026-10-23T16:59:43.714Z 0.6 https://www.clinicalobserver.com/policy/fda-adds-advisers-as-review-finds-pharma-ties 2026-10-22T20:28:02.241Z 0.6 https://www.clinicalobserver.com/research/retatrutide-and-amylin-combos-move-toward-regulatory-decisions 2026-10-25T14:00:28.363Z 0.6 https://www.clinicalobserver.com/hospitals/mass-general-brigham-nurses-withdraw-strike-notice 2026-10-24T17:27:52.422Z 0.6 https://www.clinicalobserver.com/public-health/us-measles-count-reaches-3-659-as-outbreaks-spread 2026-10-23T19:26:00.765Z 0.6 https://www.clinicalobserver.com/policy/fda-advisory-panel-recommends-grails-galleri-blood-test 2026-10-22T22:56:03.837Z 0.6 https://www.clinicalobserver.com/about monthly 0.2 https://www.clinicalobserver.com/standards monthly 0.2 https://www.clinicalobserver.com/corrections monthly 0.2 https://www.clinicalobserver.com/ownership monthly 0.2 https://www.clinicalobserver.com/contact monthly 0.2 https://www.clinicalobserver.com/advertise monthly 0.2 https://www.clinicalobserver.com/newsletter monthly 0.2 https://www.clinicalobserver.com/careers monthly 0.2 https://www.clinicalobserver.com/privacy monthly 0.2 https://www.clinicalobserver.com/terms monthly 0.2 https://www.clinicalobserver.com/cookies monthly 0.2 https://www.clinicalobserver.com/accessibility monthly 0.2